Spire Wealth Management Dr Reddys Laboratories LTD Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Spire Wealth Management holds 290 shares of RDY stock, worth $4,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290
Previous 290
-0.0%
Holding current value
$4,123
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RDY
# of Institutions
261Shares Held
92.3MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.12.2MShares$173 Million0.3% of portfolio
-
Royal Bank Of Canada Toronto, A69.96MShares$142 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.01MShares$128 Million0.19% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$90.4 Million28.64% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.4MShares$76.8 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.36B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...